Adjunctive oxcarbazepine in comorbid anxiety and affective disorder with hyponatremic seizure: Case analysis and literature review

Epilepsy and Behavior

Volumn 4, Issue 6, 2003, Pages 766-770

  Kaufman, Kenneth R ^a   Gerner, Robert ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adverse effects; Anticonvulsants; Antidepressants; Anxiety; Bipolar; Depression; Epilepsy; Hyponatremia; Oxcarbazepine; Prevalence; Psychiatric disorders; Seizure; Sexual dysfunction; Subclincal hypothyroidism; Treatment

Indexed keywords

CLOMIPRAMINE; GABAPENTIN; LEVOTHYROXINE; LORAZEPAM; NEFAZODONE; OXCARBAZEPINE; PHENELZINE; THYROTROPIN; THYROXINE; VALPROIC ACID; VENLAFAXINE;

ADULT; ANORGASMIA; ANXIETY DISORDER; CASE REPORT; COMORBIDITY; DOSE RESPONSE; ELECTROENCEPHALOGRAM; FATIGUE; FREE THYROXINE INDEX; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPONATREMIA; LABORATORY TEST; MAJOR DEPRESSION; MALE; MOOD DISORDER; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RATING SCALE; REVIEW; SEIZURE; SYMPTOMATOLOGY; TONIC CLONIC SEIZURE;

EID: 0348048750     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2003.08.007     Document Type: Article

References (64)

1. Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 1998;155:12-21.
2. Post RM, Ketter TA, Pazzaglia PJ, et al. Rational polypharmacy in the bipolar affective disorders. Epilepsy Res 1996;11(Suppl): 153-80.
3. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159(4, Suppl):1-50.
4. Ketter TA, Wang PW, Becker OV, Nowakowska C, Yang Y. The diverse roles of anticonvulsants in bipolar disorders. Ann Clin Psychiatry 2003; 15:95-108.
5. Guay DR. The emerging role of valproate in bipolar disorder and other psychiatric disorders. Pharmacotherapy 1995;15:631-47.
6. Kaufman KR, Lepore FE, Keyser RJ. Visual fields and tiagabine: a quandary. Seizure 2001;10:525-9.
7. Asconape JJ. Some common issues in the use of antiepileptic drugs. Semin Neurol 2002;22:27-39.
8. Beydoun A, Kutluay E. Oxcarbazepine. Expert Opin Pharmacother 2002;3:59-71.
9. Barcs G, Walker EB, Elger CE, et al. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 2000;41:1597-607.
10. Ramsay RE, Wilder BJ. Metabolism of tricyclic anticonvulsant drugs. Epilepsy Behav 2002;3(3,P2):S2-6.
11. Gilham RA, Williams N, Wiedmann K, Butler E, Larkin JG, Brodie M. Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients. J Neurol Neurosurg Psychiatry 1988;51:929-33.
12. Potter JM, Donnelly A. Carbamazepine-10,11-epoxide in therapeutic drug monitoring. Ther Drug Monit 1998;20:652-7.
13. Baruzzi A, Albani F, Riva R. Oxcarbazepine: pharmacokinetic interactions and their clinical relevance. Epilepsia 1994;35(Suppl 3):S14-9.
14. Emrich HM, Gunther R, Dose M. Current perspective in the pharmacotherapy of depression and mania. Neuropharmacology 1983;22(3, Spec. No.):358.
15. Emrich HM, Altmann H, Dose M, von Zerssen D. Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report. Therapeutic Biochem Behav 1983;19:369-72.
16. Emrich HM, Zerssen D. New concepts for therapy of manic and depressive disorders. Seishin Shinkeigaku Zasshi 1983;85:621-3.
17. Dietrich DF, Kropp S, Emrich HM. Oxcarbazepine in affective and schizoaffective disorders. Pharmacopsychiatry 2001;34:242-50.
18. Schmidt D, Arroyo S, Baulac M, et al. Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view. Acta Neurol Scand 2001;104:167-70.
19. Smith PEM. For The UK Oxcarbazepine Advisory Board: clinical recommendations for oxcarbazepine. Seizure 2001;10:87-91.
20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
21. Windhaber J, Maierhofer D, Dantendorfer K. Oxcarbazepine for panic disorder occurring after two grand mal seizures: a case report. J Clin Psychiatry 1997;58:404-5.
22. Michael A, Tubbe PA, Praseedom A. Sertraline-induced anorgasmia reversed by nefazodone. Br J Psychiatry 1999;175:491.
23. Brannon GE, Rolland PD. Anorgasmia in a patient with bipolar disorder type 1 treated with gabapentin. J Clin Psychopharmacol 2000;20:379-81.
24. Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia 1994;35:181-8.
25. Hauser WA. Incidence and prevalence. In: Engel J, Pedley TA, editors. Epilepsy, a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers; 1997. p. 47-57.
26. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-8.
27. Weissman MM, Leaf PJ, Tischler GL, et al. Affective disorders in five United States communities. Psychol Med 1988;18:141-53.
28. Schatzberg AF. Overview of anxiety disorders: prevalence, biology, course, and treatment. J Clin Psychiatry 1991;52(7, Suppl):5-9.
29. Merikangas KR, Avenevoli S, Acharyya S, Zhang H, Angst J. The spectrum of social phobia in the Zurich cohort study of young adults. Biol Psychiatry 2002;51:81-91.
30. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000;59(Suppl 1):S5-S30.
31. Leinonen E, Lepola U, Koponen H. Substituting carbamazepine with oxcarbazepine increases citalopram levels: a report on two cases. Pharmacopsychiatry 1996;29:156-8.
32. Kaufman KR, Gerner R. Lamotrigine toxicity secondary to sertraline. Seizure 1998;7:163-5.
33. Deckers CL, Kekster YA, Keyser A, Manners MW, Meinardi H, Renier WO. Adverse effects in epilepsy therapy: wait and see or go for it? Acta Neurol Scand 1997;95:248-52.
34. Husain AM, Carwile ST, Miller PP, Radtke RA. Improved sexual function in three men taking lamotrigine for epilepsy. South Med J 2000;93:335-6.
35. Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002;36:1577-89.
36. Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antidepressants: a review. J Clin Psychiatry 1993;54:289-99.
37. Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf 2002;25:91-110.
38. Siegler EL, Tamres D, Berlin JA, Allen-Taylor L, Strom BL. Risk factors for the development of hyponatremia in psychiatric inpatients. Arch Intern Med 1995;155:953-7.
39. Kirby D, Harrigan S, Ames D. Hyponatremia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry 2002;17:231-7.
40. Movig KL, Leufkens HG, Lenderink AW, et al. Association between antidepressant drug use and hyponatremia: a case-controlled study. Br J Clin Pharmacol 2002;53:363-9.
41. Pledger DR, Mathew H. Hyponatremia and clomipramine therapy. Br J Psychiatry 1989;154:263-4.
42. Joffe RT, Levitt AJ. Major depression and subclinical (grade 2) hypothyroidism. Psychoneuroendocrinology 1992;17(2/3):215-21.
43. Cleare AJ, McGregor A, O'Keane V. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity, and depression. Clin Endocrinol (Oxford) 1995;43:713-9.
44. Hickie I, Bennett B, Mitchell P, Wilhelm K, Orlay W. Clinical and subclinical hypothyroidism in patients with chronic and treatment resistant depression. Aust NZ J Psychiatry 1996;30:246-52.
45. Woeber KA. Subclinical thyroid dysfunction. Arch Intern Med 1997;157:1065-8.
46. Simon NM, Blacker D, Korbly NB, et al. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J Affect Disord 2002;69:209-17.
47. Weissman MM, Fyer AJ, Haghighi F, et al. Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet 2000;96:24-35.
48. Jabbari B, Huott AD. Seizures in thyrotoxicosis. Epilepsia 1980;21:91-6.
49. Tachman ML, Guthrie Jr GP. Hypothyroidism: diversity of presentation. Endocr Rev 1984;5:456-65.
50. Sundaram MB, Hill A, Lowry N. Thyroxine-induced petit mal status epilepticus. Neurology 1985;35:1792-3.
51. Mills SA, Savage DD. Evidence of hypothyroidism in the genetically epilepsy-prone rat. Epilepsy Res 1988;2:102-10.
52. Bryce GM, Poyner F. Myxoedema presenting with seizures. Postgrad Med J 1992;68:35-6.
53. Su YH, Izumi T, Kitsu M, Fukuyama Y. Seizure threshold in juvenile myoclonic epilepsy with Graves disease. Epilepsia 1993;34:488-92.
54. Li Voon Chong JS, Lecky BR, Macfarlane IA. Recurrent encephalopathy and generalized associated with relapses of thyrotoxicosis. Int J Clin Pract 2000;54:621-2.
55. Pacheco-Rosado J, Angeles-Lopez L. Facilitation of pentylene tetrazole-kindled seizures by mild thyroid hormone deficiencies. Proc West Pharmacol Soc 1997;40:75-7.
56. Pacheco-Rosado J, Quevado-Corona L, Zamudio-Herniandez SR, Chambert G. T3 deficiency prolongs convulsions induced by acute pentylenetetrazole. Horm Metab Res 1997;29:577-9.
57. Pacheco-Rosada J, Zamudio-Hernandez S, Chambert G. Thyroid hormones modified susceptibility to lidocaine-kindling in rats. Life Sci 2001;69:2575-82.
58. Macaron C, Famuyiwa O. Hyponatremia of hypothyroidism. Appropriate suppression of antidiuretic hormone. Arch Intern Med 1978;138:820-2.
59. Montenegro J, Gonzalez O, Saracho R, Aguirre R, Martine I. Changes in renal function in primary hypothyroidism. Am J Kidney Dis 1996;27:195-8.
60. Hierholzer K, Finke R. Myxedema. Kidney Int Suppl 1997;59:S82-9.
61. Hanna FWF, Scanlon MF. Hyponatremia, hypothyroidism, and the role of arginine-vasopressin. Lancet 1997;350:755-6.
62. Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician 2000;62:2485-90.
63. Baajafer FS, Hammami MM, Mohammed GE. Prevalence and severity of hyponatremia and hypercreatinimemia in short-term uncomplicated hypothyroidism. J Endocrinol Invest 1999;22: 35-9.
64. Croal BL, Blake AM, Johnston J, Glen AC, O'Reilly DS. Absence of relation between hyponatremia amd hypothyroidism. Lancet 1997;350:1402.